Manyazewal Tsegahun, Woldeamanuel Yimtubezinash, Blumberg Henry M, Fekadu Abebaw, Marconi Vincent C
Addis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia.
Emory University School of Medicine and Rollins School of Public Health, Atlanta, GA, USA.
NPJ Digit Med. 2021 Aug 17;4(1):125. doi: 10.1038/s41746-021-00487-4.
The World Health Organization (WHO) recently put forth a Global Strategy on Digital Health 2020-2025 with several countries having already achieved key milestones. We aimed to understand whether and how digital health technologies (DHTs) are absorbed in Africa, tracking Ethiopia as a key node. We conducted a systematic review, searching PubMed-MEDLINE, Embase, ScienceDirect, African Journals Online, Cochrane Central Registry of Controlled Trials, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform databases from inception to 02 February 2021 for studies of any design that investigated the potential of DHTs in clinical or public health practices in Ethiopia. This review was registered with PROSPERO ( CRD42021240645 ) and it was designed to inform our ongoing DHT-enabled randomized controlled trial (RCT) (ClinicalTrials.gov ID: NCT04216420 ). We found 27,493 potentially relevant citations, among which 52 studies met the inclusion criteria, comprising a total of 596,128 patients, healthy individuals, and healthcare professionals. The studies involved six DHTs: mHealth (29 studies, 574,649 participants); electronic health records (13 studies, 4534 participants); telemedicine (4 studies, 465 participants); cloud-based application (2 studies, 2382 participants); information communication technology (3 studies, 681 participants), and artificial intelligence (1 study, 13,417 participants). The studies targeted six health conditions: maternal and child health (15), infectious diseases (14), non-communicable diseases (3), dermatitis (1), surgery (4), and general health conditions (15). The outcomes of interest were feasibility, usability, willingness or readiness, effectiveness, quality improvement, and knowledge or attitude toward DHTs. Five studies involved RCTs. The analysis showed that although DHTs are a relatively recent phenomenon in Ethiopia, their potential harnessing clinical and public health practices are highly visible. Their adoption and implementation in full capacity require more training, access to better devices such as smartphones, and infrastructure. DHTs hold much promise tackling major clinical and public health backlogs and strengthening the healthcare ecosystem in Ethiopia. More RCTs are needed on emerging DHTs including artificial intelligence, big data, cloud, cybersecurity, telemedicine, and wearable devices to provide robust evidence of their potential use in such settings and to materialize the WHO's Global Strategy on Digital Health.
世界卫生组织(WHO)最近提出了《2020 - 2025年全球数字健康战略》,已有几个国家实现了关键里程碑。我们旨在了解数字健康技术(DHTs)在非洲是否以及如何被采用,并将埃塞俄比亚作为关键节点进行追踪。我们进行了一项系统综述,检索了PubMed - MEDLINE、Embase、ScienceDirect、非洲在线期刊、Cochrane对照试验中央注册库、ClinicalTrials.gov以及WHO国际临床试验注册平台数据库,检索时间从建库至2021年2月2日,以查找任何设计的研究,这些研究调查了DHTs在埃塞俄比亚临床或公共卫生实践中的潜力。该综述已在PROSPERO(CRD42021240645)注册,旨在为我们正在进行的基于DHTs的随机对照试验(RCT)(ClinicalTrials.gov标识符:NCT04216420)提供参考。我们发现了27493条潜在相关引文,其中52项研究符合纳入标准,共涉及596128名患者、健康个体和医疗保健专业人员。这些研究涉及六种DHTs:移动健康(29项研究,574649名参与者);电子健康记录(13项研究,4534名参与者);远程医疗(4项研究,465名参与者);基于云的应用程序(2项研究,2382名参与者);信息通信技术(3项研究,681名参与者),以及人工智能(1项研究,13417名参与者)。这些研究针对六种健康状况:母婴健康(15项)、传染病(14项)、非传染性疾病(3项)、皮炎(1项)、手术(4项),以及一般健康状况(15项)。感兴趣的结果包括可行性、可用性、意愿或准备情况、有效性、质量改进,以及对DHTs的知识或态度。五项研究涉及随机对照试验。分析表明,尽管DHTs在埃塞俄比亚是一个相对较新的现象,但它们在临床和公共卫生实践中的潜在应用非常明显。要全面采用和实施这些技术,需要更多培训、获得更好的设备(如智能手机)以及基础设施。DHTs在解决埃塞俄比亚主要的临床和公共卫生积压问题以及加强医疗生态系统方面具有很大潜力。需要针对包括人工智能、大数据、云、网络安全、远程医疗和可穿戴设备在内的新兴DHTs开展更多随机对照试验,以提供其在此类环境中潜在用途的有力证据,并实现WHO的全球数字健康战略。